anticoagulation

Rivaroxaban Shown to Cut Risk of Cardiovascular EventsRivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
Patient and Physician Education Boosts Anticoagulant Adherence RatesEducation about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.
Cardiac MattersReversal Agents for Direct-Acting Oral Anticoagulants
Oral Anticoagulant Safety, Apixaban, Statins and VTEAccording to a recent report from the Institute of Safe Medication practices (ISMP), FDA received 34,765 adverse drug event reports for oral anticoagulants in 2015.
Regs, robbery responses among top “pharmacy gamechangers” for 2016
Regs, robbery responses among top “pharmacy gamechangers” for 2016The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.
Compression stockings, AF patients at risk, and ICH outcomesAnticoagulation briefs.
Fall-related ICH incidence in elderly on warfarinA study of nearly 32,000 aging veterans revealed the unsuspected vulnerability of this population.
The expanding role of direct oral anticoagulants in the management of thromboembolic disease
The expanding role of direct oral anticoagulants in the management of thromboembolic diseaseThe goal of this program for pharmacists and technicians is to review the treatment of venous thromboembolism with the class of medications known as direct oral anticoagulants.
Antithrombotic therapy to prevent migraine attacks after ASD closureClopidogrel therapy can make a difference after ASD closures.
Pre-op anticoagulation reduces VTE risk in cancer patientsResearchers found that rates of DVT and PE were significantly lower among patients who received preoperative chemoprophylaxis than in those who did not.